A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial.
George AK, Miocinovic R, Patel AR, Lomas DJ, Correa AF, Chen DYT, Rastinehad AR, Schwartz MJ, Uchio EM, Sidana A, Helfand BT, Gahan JC, Yu A, Vourganti S, Barqawi AB, Brisbane WG, Wysock JS, Polascik TJ, McClure TD, Coleman JA.
George AK, et al. Among authors: sidana a.
Cancers (Basel). 2024 Jun 8;16(12):2178. doi: 10.3390/cancers16122178.
Cancers (Basel). 2024.
PMID: 38927884
Free PMC article.